There is significant value still left in the suite of drugs that Mesoblast trialled and that missed endpoints, potentially billions in the hands of the right major global pharmaceutical company. As for the share price, I'd rather be in Mesoblast today at its current share price and awaiting potential offers or take over offers, or re-occurring revenues from the drug suite. We have all the answers and the pieces of the puzzle, it just needs to be carefully put together now.
MSB Price at posting:
$2.49 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)